Imperial College have published an innovative study in the BCS demonstrating that adverse symptom related to statin, placebo or no treatment. The study design was innovative and the clear result showed that 90% of the induced adversity symptoms could also be induced by placebo. This is a critical message for all those treating patients with elevated cardiac risk.
